Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease.

Buzzetti E, Hall A, Ekstedt M, Manuguerra R, Guerrero Misas M, Covelli C, Leandro G, Luong T, Kechagias S, Manesis EK, Pinzani M, Dhillon AP, Tsochatzis EA.

Aliment Pharmacol Ther. 2019 May;49(9):1214-1222. doi: 10.1111/apt.15219. Epub 2019 Mar 18.

PMID:
30882933
2.

Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease.

Stasi C, Tsochatzis EA, Hall A, Rosenberg W, Milani S, Dhillon AP, Pinzani M.

Dig Liver Dis. 2019 Jul;51(7):1001-1007. doi: 10.1016/j.dld.2018.12.005. Epub 2018 Dec 19.

PMID:
30606698
3.

ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection.

Thi EP, Dhillon AP, Ardzinski A, Bidirici-Ertekin L, Cobarrubias KD, Cuconati A, Kondratowicz AS, Kwak K, Li AHL, Miller A, Pasetka C, Pei L, Phelps JR, Snead NM, Wang X, Ye X, Sofia MJ, Lee ACH.

ACS Infect Dis. 2019 May 10;5(5):725-737. doi: 10.1021/acsinfecdis.8b00191. Epub 2018 Nov 19.

PMID:
30403127
4.

Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition.

Guido M, Alves VAF, Balabaud C, Bathal PS, Bioulac-Sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell LD, Gill RM, Hytiroglou P, Nakanuma Y, Paradis V, Quaglia A, Rautou PE, Theise ND, Thung S, Tsui WMS, Sempoux C, Snover D, van Leeuwen DJ; International Liver Pathology Study Group.

Histopathology. 2019 Jan;74(2):219-226. doi: 10.1111/his.13738. Epub 2018 Oct 17. Review.

PMID:
30129657
5.

Acute-on-chronic liver failure 2018: a need for (urgent) liver biopsy?

van Leeuwen DJ, Alves V, Balabaud C, Bhathal PS, Bioulac-Sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell L, Gill RM, Guido M, Hytiroglou P, Nakanuma Y, Paradis V, Rautou PE, Sempoux C, Snover DC, Theise ND, Thung SN, Tsui WMS, Quaglia A, Liver Pathology Study Group TI.

Expert Rev Gastroenterol Hepatol. 2018 Jun;12(6):565-573. doi: 10.1080/17474124.2018.1481388. Epub 2018 Jun 14. Review.

PMID:
29806950
6.

Transaminase abnormalities and adaptations of the liver lobule manifest at specific cut-offs of steatosis.

Hall A, Covelli C, Manuguerra R, Luong TV, Buzzetti E, Tsochatzis E, Pinzani M, Dhillon AP.

Sci Rep. 2017 Jan 20;7:40977. doi: 10.1038/srep40977.

7.

Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation.

Quaglia A, Alves VA, Balabaud C, Bhathal PS, Bioulac-Sage P, Crawford JM, Dhillon AP, Ferrell L, Guido M, Hytiroglou P, Nakanuma Y, Paradis V, Snover DC, Theise ND, Thung SN, Tsui WM, van Leeuwen DJ; International Liver Pathology Study Group.

Histopathology. 2016 Jun;68(7):953-67. doi: 10.1111/his.12957. Epub 2016 Apr 28. Review.

PMID:
26918878
8.

Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation.

Mazza G, Rombouts K, Rennie Hall A, Urbani L, Vinh Luong T, Al-Akkad W, Longato L, Brown D, Maghsoudlou P, Dhillon AP, Fuller B, Davidson B, Moore K, Dhar D, De Coppi P, Malago M, Pinzani M.

Sci Rep. 2015 Aug 7;5:13079. doi: 10.1038/srep13079.

9.

Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy.

Rodríguez-Perálvarez M, García-Caparrós C, Tsochatzis E, Germani G, Hogan B, Poyato-González A, O'Beirne J, Senzolo M, Guerrero-Misas M, Montero-Álvarez JL, Patch D, Barrera P, Briceño J, Dhillon AP, Burra P, Burroughs AK, De la Mata M.

Transpl Int. 2015 Apr;28(4):455-64. doi: 10.1111/tri.12514. Epub 2015 Jan 16.

10.

Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria.

Parisi I, Tsochatzis E, Wijewantha H, Rodríguez-Perálvarez M, De Luca L, Manousou P, Fatourou E, Pieri G, Papastergiou V, Davies N, Yu D, Luong T, Dhillon AP, Thorburn D, Patch D, O'Beirne J, Meyer T, Burroughs AK.

Liver Transpl. 2014 Nov;20(11):1327-35. doi: 10.1002/lt.23969.

11.

Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.

Mohamed FE, Al-Jehani RM, Minogue SS, Andreola F, Winstanley A, Olde Damink SW, Habtesion A, Malagó M, Davies N, Luong TV, Dhillon AP, Mookerjee RP, Dhar DK, Jalan R.

Liver Int. 2015 Mar;35(3):1063-76. doi: 10.1111/liv.12626. Epub 2014 Jul 30.

PMID:
24990399
12.

The use of guideline images to improve histological estimation of hepatic steatosis.

Hall AR, Green AC, Luong TV, Burroughs AK, Wyatt J, Dhillon AP.

Liver Int. 2014 Oct;34(9):1414-27. doi: 10.1111/liv.12614. Epub 2014 Jul 8.

PMID:
24905412
13.

Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies.

Maybury CM, Jabbar-Lopez ZK, Wong T, Dhillon AP, Barker JN, Smith CH.

Br J Dermatol. 2014 Jul;171(1):17-29. doi: 10.1111/bjd.12941. Epub 2014 Jul 15. Review.

PMID:
24606161
14.

Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis.

Tsochatzis E, Bruno S, Isgro G, Hall A, Theocharidou E, Manousou P, Dhillon AP, Burroughs AK, Luong TV.

J Hepatol. 2014 May;60(5):948-54. doi: 10.1016/j.jhep.2013.12.023. Epub 2014 Jan 8.

15.

Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.

Manousou P, Cholongitas E, Samonakis D, Tsochatzis E, Corbani A, Dhillon AP, Davidson J, Rodríguez-Perálvarez M, Patch D, O'Beirne J, Thorburn D, Luong T, Rolles K, Davidson B, McCormick PA, Hayes P, Burroughs AK.

Gut. 2014 Jun;63(6):1005-13. doi: 10.1136/gutjnl-2013-305606. Epub 2013 Oct 16.

16.

HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers.

Larsson SB, Eilard A, Malmström S, Hannoun C, Dhillon AP, Norkrans G, Lindh M.

Liver Int. 2014 Aug;34(7):e238-45. doi: 10.1111/liv.12345. Epub 2013 Oct 25.

PMID:
24118747
17.

Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates.

Ala A, Brown D, Khan K, Standish R, Odin JA, Fiel MI, Schiano TD, Hillan KJ, Rahman SA, Hodgson HJ, Dhillon AP.

Dig Dis Sci. 2013 Sep;58(9):2528-41. doi: 10.1007/s10620-013-2755-1. Epub 2013 Jul 10.

PMID:
23839340
18.

Hepatic steatosis estimated microscopically versus digital image analysis.

Hall AR, Dhillon AP, Green AC, Ferrell L, Crawford JM, Alves V, Balabaud C, Bhathal P, Bioulac-Sage P, Guido M, Hytiroglou P, Nakanuma Y, Paradis V, Quaglia A, Snover D, Theise N, Thung S, Tsui W, van Leeuwen DJ.

Liver Int. 2013 Jul;33(6):926-35. doi: 10.1111/liv.12162. Epub 2013 Apr 7.

PMID:
23560780
19.

Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma.

Tsochatzis E, Garcovich M, Marelli L, Papastergiou V, Fatourou E, Rodriguez-Peralvarez ML, Germani G, Davies N, Yu D, Luong TV, Dhillon AP, Thorburn D, Patch D, O'Beirne J, Meyer T, Burroughs AK.

Liver Int. 2013 Jul;33(6):944-9. doi: 10.1111/liv.12144. Epub 2013 Mar 26.

PMID:
23530918
20.

Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation.

Manousou P, Burroughs AK, Tsochatzis E, Isgro G, Hall A, Green A, Calvaruso V, Ma GL, Gale J, Burgess G, O'Beirne J, Patch D, Thorburn D, Leandro G, Dhillon AP.

J Hepatol. 2013 May;58(5):962-8. doi: 10.1016/j.jhep.2012.12.016. Epub 2012 Dec 20. Erratum in: J Hepatol. 2013 Aug;59(2):402. Sochatzis, Emmanuel T [corrected to Tsochatzis, Emmanuel].

PMID:
23262247
21.

A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.

Rodríguez-Perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK.

Ann Surg Oncol. 2013 Jan;20(1):325-39. doi: 10.1245/s10434-012-2513-1. Epub 2012 Nov 13. Review.

PMID:
23149850
22.

Sample size requirement for digital image analysis of collagen proportionate area in cirrhotic livers.

Hall AR, Tsochatzis E, Morris R, Burroughs AK, Dhillon AP.

Histopathology. 2013 Feb;62(3):421-30. doi: 10.1111/his.12010. Epub 2012 Nov 8.

PMID:
23134419
23.

The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis.

Isgro G, Calvaruso V, Andreana L, Luong TV, Garcovich M, Manousou P, Alibrandi A, Maimone S, Marelli L, Davies N, Patch D, Dhillon AP, Burroughs AK.

J Gastroenterol. 2013 Aug;48(8):921-9. doi: 10.1007/s00535-012-0694-9. Epub 2012 Nov 3.

PMID:
23124603
24.

Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome.

Rodríguez-Perálvarez M, Germani G, Papastergiou V, Tsochatzis E, Thalassinos E, Luong TV, Rolando N, Dhillon AP, Patch D, O'Beirne J, Thorburn D, Burroughs AK.

J Hepatol. 2013 Feb;58(2):262-70. doi: 10.1016/j.jhep.2012.09.019. Epub 2012 Sep 27.

PMID:
23023010
25.

Regression of fibrosis: the need for quantitative methods of assessment.

Tsochatzis EA, Manousou P, Dhillon AP, Burroughs AK.

J Hepatol. 2012 Dec;57(6):1391; author reply 1392. doi: 10.1016/j.jhep.2012.06.039. Epub 2012 Jul 31. No abstract available.

26.

Spectroscopic photoacoustic imaging of lipid-rich plaques in the human aorta in the 740 to 1400 nm wavelength range.

Allen TJ, Hall A, Dhillon AP, Owen JS, Beard PC.

J Biomed Opt. 2012 Jun;17(6):061209. doi: 10.1117/1.JBO.17.6.061209.

27.

Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation.

Calvaruso V, Dhillon AP, Tsochatzis E, Manousou P, Grillo F, Germani G, Patch D, O'Beirne J, Burroughs AK.

J Gastroenterol Hepatol. 2012 Jul;27(7):1227-32. doi: 10.1111/j.1440-1746.2012.07136.x.

PMID:
22432427
28.

Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count.

Rodríguez-Perálvarez M, Germani G, Tsochatzis E, Rolando N, Luong TV, Dhillon AP, Thorburn D, O'Beirne J, Patch D, Burroughs AK.

Transpl Int. 2012 May;25(5):555-63. doi: 10.1111/j.1432-2277.2012.01457.x. Epub 2012 Mar 15.

29.

Fibrosis distribution in explanted cirrhotic livers.

Hall A, Germani G, Isgrò G, Burroughs AK, Dhillon AP.

Histopathology. 2012 Jan;60(2):270-7. doi: 10.1111/j.1365-2559.2011.04094.x.

PMID:
22211285
30.

Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group.

Hytiroglou P, Snover DC, Alves V, Balabaud C, Bhathal PS, Bioulac-Sage P, Crawford JM, Dhillon AP, Ferrell L, Guido M, Nakanuma Y, Paradis V, Quaglia A, Theise ND, Thung SN, Tsui WM, van Leeuwen DJ.

Am J Clin Pathol. 2012 Jan;137(1):5-9. doi: 10.1309/AJCP2T2OHTAPBTMP.

PMID:
22180471
31.

Noninvasive assessment of liver fibrosis: the clinical context and question are important.

Tsochatzis EA, Germani G, Dhillon AP, Burroughs AK.

Hepatology. 2011 Dec;54(6):2276. doi: 10.1002/hep.24566. No abstract available.

PMID:
21793024
32.

Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients.

Manousou P, Kalambokis G, Grillo F, Watkins J, Xirouchakis E, Pleguezuelo M, Leandro G, Arvaniti V, Germani G, Patch D, Calvaruso V, Mikhailidis DP, Dhillon AP, Burroughs AK.

Liver Int. 2011 May;31(5):730-9. doi: 10.1111/j.1478-3231.2011.02488.x. Epub 2011 Mar 6.

PMID:
21457446
33.

Noninvasive assessment of liver fibrosis: the need for better validation.

Tsochatzis EA, Germani G, Hall A, Anousou PM, Dhillon AP, Burroughs AK.

Hepatology. 2011 May;53(5):1781-2; author reply 1782-3. doi: 10.1002/hep.24271. No abstract available.

PMID:
21384400
34.

Assessment of fibrosis and cirrhosis in liver biopsies: an update.

Germani G, Hytiroglou P, Fotiadu A, Burroughs AK, Dhillon AP.

Semin Liver Dis. 2011 Feb;31(1):82-90. doi: 10.1055/s-0031-1272836. Epub 2011 Feb 22. Review.

PMID:
21344353
35.

Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.

Manousou P, Dhillon AP, Isgro G, Calvaruso V, Luong TV, Tsochatzis E, Xirouchakis E, Kalambokis G, Cross TJ, Rolando N, O'Beirne J, Patch D, Thornburn D, Burroughs AK.

Liver Transpl. 2011 Feb;17(2):178-88. doi: 10.1002/lt.22209.

36.

Validating non-invasive markers of fibrosis: the need for a new histological reference standard.

Tsochatzis EA, Manousou P, Fede G, Dhillon AP, Burroughs AK.

Gut. 2011 Oct;60(10):1442-3; author reply 1443-4. doi: 10.1136/gut.2010.229484. Epub 2010 Dec 15. No abstract available.

PMID:
21159895
37.

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.

Bodin K, Ellmerich S, Kahan MC, Tennent GA, Loesch A, Gilbertson JA, Hutchinson WL, Mangione PP, Gallimore JR, Millar DJ, Minogue S, Dhillon AP, Taylor GW, Bradwell AR, Petrie A, Gillmore JD, Bellotti V, Botto M, Hawkins PN, Pepys MB.

Nature. 2010 Nov 4;468(7320):93-7. doi: 10.1038/nature09494. Epub 2010 Oct 20.

38.

The relationship between liver disease stage and liver fibrosis: a tangled web.

Germani G, Burroughs AK, Dhillon AP.

Histopathology. 2010 Dec;57(6):773-84. doi: 10.1111/j.1365-2559.2010.03609.x. Epub 2010 Aug 31. Review.

PMID:
20812954
39.

Severe, acute liver injury and khat leaves.

Chapman MH, Kajihara M, Borges G, O'Beirne J, Patch D, Dhillon AP, Crozier A, Morgan MY.

N Engl J Med. 2010 Apr 29;362(17):1642-4. doi: 10.1056/NEJMc0908038. No abstract available.

PMID:
20427816
40.

The histogenesis of regenerative nodules in human liver cirrhosis.

Lin WR, Lim SN, McDonald SA, Graham T, Wright VL, Peplow CL, Humphries A, Kocher HM, Wright NA, Dhillon AP, Alison MR.

Hepatology. 2010 Mar;51(3):1017-26. doi: 10.1002/hep.23483.

PMID:
20198634
41.

Are FoxP3(+) cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C?

Westin J, Hellstrand K, Dhillon AP, Lagging M; DITTO-HCV Study Group.

J Viral Hepat. 2011 Feb;18(2):149-51. doi: 10.1111/j.1365-2893.2010.01277.x.

PMID:
20196808
42.

Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.

Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.

Liver Transpl. 2009 Dec;15(12):1783-91. doi: 10.1002/lt.21907.

43.

A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.

Cross TJ, Calvaruso V, Foxton MR, Manousou P, Quaglia A, Grillo F, Dhillon AP, Nolan J, Chang TP, O'Grady J, Heneghan MA, O'Beirne JP, Burroughs AK, Harrison PM.

J Viral Hepat. 2010 Sep;17(9):640-9. doi: 10.1111/j.1365-2893.2009.01222.x. Epub 2009 Nov 17.

PMID:
19922441
44.

Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.

Cross TJ, Calvaruso V, Maimone S, Carey I, Chang TP, Pleguezuelo M, Manousou P, Quaglia A, Grillo F, Dhillon AP, Dusheiko GM, Burroughs AK, Harrison PM.

J Viral Hepat. 2010 Aug;17(8):546-54. doi: 10.1111/j.1365-2893.2009.01210.x. Epub 2009 Oct 27.

PMID:
19874477
45.

Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity.

Manousou P, Arvaniti V, Tsochatzis E, Isgro G, Jones K, Shirling G, Dhillon AP, O'Beirne J, Patch D, Burroughs AK.

Liver Transpl. 2010 Jan;16(1):64-73. doi: 10.1002/lt.21960.

46.

Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy.

Maniaci V, Davidson BR, Rolles K, Dhillon AP, Hackshaw A, Begent RH, Meyer T.

Eur J Surg Oncol. 2009 Jun;35(6):617-21. doi: 10.1016/j.ejso.2008.12.009. Epub 2009 Jan 13.

PMID:
19144491
47.

Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient.

Calvaruso V, Burroughs AK, Standish R, Manousou P, Grillo F, Leandro G, Maimone S, Pleguezuelo M, Xirouchakis I, Guerrini GP, Patch D, Yu D, O'Beirne J, Dhillon AP.

Hepatology. 2009 Apr;49(4):1236-44. doi: 10.1002/hep.22745.

PMID:
19133646
48.

A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection.

Westin J, Ydreborg M, Islam S, Alsiö A, Dhillon AP, Pawlotsky JM, Zeuzem S, Schalm SW, Ferrari C, Neumann AU, Hellstrand K, Lagging M; DITTO-HCV Study Group.

Scand J Gastroenterol. 2008 Jan;43(1):73-80.

PMID:
18938750
49.

Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient.

Kalambokis G, Manousou P, Samonakis D, Grillo F, Dhillon AP, Patch D, O'Beirne J, Rolles K, Burroughs AK.

Transpl Int. 2009 Feb;22(2):172-81. doi: 10.1111/j.1432-2277.2008.00744.x. Epub 2008 Sep 10.

50.

Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.

Marelli L, Grasso A, Pleguezuelo M, Martines H, Stigliano R, Dhillon AP, Patch D, Davidson BR, Sharma D, Rolles K, Burroughs AK.

Ann Surg Oncol. 2008 Dec;15(12):3503-11. doi: 10.1245/s10434-008-0128-3. Epub 2008 Sep 6.

PMID:
18777193

Supplemental Content

Loading ...
Support Center